期刊文献+

临床真菌感染及耐药性分析 被引量:1

下载PDF
导出
摘要 目的了解医院内常见真菌感染的来源及耐药性特点。方法收集2004年1月-12月临床常见真菌1919株,用沙保弱培养基分离,VITEK-AMS或Rapid-Yeast鉴定菌种,纸片扩散法测定其耐药性。结果各种临床真菌感染以白色念珠菌、热带念珠菌为主,分别占59.9%和25.3%。痰液标本真菌检出率最高,占42.9%,其次是尿液,占31.7%。白色念珠菌对氟康唑耐药率为0.6%、热带念珠菌2.6%、光滑念珠菌21.1%、对近平滑念珠菌14.3%、克柔念珠菌27.3%。结论医院内真菌检出以痰液标本占首位。真菌感染以白色念珠菌为主,对氟康唑等抗真菌类药物耐药率较低,而非白色念珠菌对氟康唑等抗真菌类药物耐药率较高。
出处 《浙江检验医学》 2007年第1期36-37,共2页 Zhejiang Journal of Laboratory Medicine
  • 相关文献

参考文献5

二级参考文献28

  • 1Burgener-Kairuz.P.,J.P.Zuber,P.Jaunin,et al.Rapid detection and identification of Candida albicans and Torulopsis(Candida) glabrata in Clinical specimens by species-speicific nested PCR amplification of a cytochrome P-450 lanosterol-α-demethylase(LIAl)gene fragment[J].J Clin Microbiol 1994,32:1902-7
  • 2Homayom Sanati, Paul Belanger, Rutilio Fratti, et al. A new triazole, Voriconazole(UK- 109, 496), blocks sterol biosynthesis in Candida albicens and Candida krudei[ J ]. Antimicrob Agents Chemother 1997, 41 (11): 2496-6.
  • 3F. Marco, M. A. Pfaller, S. Mesaer, et al. In vitro activities of voriconaole (UK- 109, 496) and four other antifungal agents against 394 clinical isolates of Candida spp[J]. Antimicrob Agents Chemother 1998, 42(1): 161-3.
  • 4Nicholas C. Karyotakis, M. Cecilia Dignani, Elias J. Anaissie.SCH 51048, anew antifungal triazole active against hematogenous Candida krusei infections in neutropenic mice[ J ]. Antimicrob Agents Chemother 1995, 39 (3): 775-7.
  • 5ER-30346[J].Drugs Fut, 1998, 23 (1): 89.
  • 6ER-30346[J]. Drugs Fut, 1999, 24 (1): 86-88.
  • 7D0870[J].Drugs Fut,,1998, 23 (5): 543-544.
  • 8D0870[J].Drugs Fut, 1997, 225 (5): 563-554.
  • 9Syn2869[J]. Drugs Fut, 1999, 24 (1): 30-37.
  • 10J. R. Graybill, R. Bocanegra, M. Luther, et al. Treatment of murine Candida krusei or Gandida glabrata infection with L-743, 872[J].Antimicrob Agents chemother, 1997,41(9):1937-9.

共引文献97

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部